中国首屈一指的ADC 平台和管线:自2016 年成立后,公司潜心打磨自身研发实力和药物管线,终得累累硕果:1)涵盖ADC、大分子药物、小分子靶向药的三大技术平台,其中OptiDC?是内地首批集成ADC 平台之一,在ADC 核心组件设计上有明显优势;2)基于三大平台,公司打造了一条约20 个分子的药物管线,包括至少11 个ADC 以及I/O + ADC 联用机会;3)与默沙东就ADC 资产多次达成...
Source Link中国首屈一指的ADC 平台和管线:自2016 年成立后,公司潜心打磨自身研发实力和药物管线,终得累累硕果:1)涵盖ADC、大分子药物、小分子靶向药的三大技术平台,其中OptiDC?是内地首批集成ADC 平台之一,在ADC 核心组件设计上有明显优势;2)基于三大平台,公司打造了一条约20 个分子的药物管线,包括至少11 个ADC 以及I/O + ADC 联用机会;3)与默沙东就ADC 资产多次达成...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.